ABBV

NYSE AbbVie, Inc.
Sep 28, 2026 · 11:13 PM ET EOD Market Closed

$266.28 ↑ +0.00 (+0.00%) Trading Up from the previous close of $266.28, $1.46 below the day’s high of $267.74

YTD change
+16.54%
vs 20-day SMA
+2.38%
vs 200-day SMA
+15.49%

Price ranges

Previous day
$262.59 $266.00
open $265.97 close $264.34
-$1.63 (-0.61%)
Today
$263.38 $267.74
open $264.33 now $266.28
+$1.95 (+0.74%)
Past week
$261.23 $269.39
from $263.96 now $266.28
+$2.32 (+0.88%)
Past month
$246.77 $269.39
from $258.15 now $266.28
+$8.13 (+3.15%)
This year
$190.75 $269.39
from $228.49 now $266.28
+$37.79 (+16.54%)

Price & Performance

+53.16 (+24.94%) / 6M

$191.87$218.51$245.15$271.79Mar 30Jun 29Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 1.2% away from all-time highs of $269.39
  • ABBV is up 17% since the beginning of the year
  • ABBV is up 21% over the past 12 months
  • ABBV is up 3% over the past 1 month
  • 1% of all ABBV investors are betting against ABBV
  • Number of investors short ABBV has gone down 14% versus last month

ABBV reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +19.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $3.65
Earnings momentum +5.5% Quarterly EPS growth
Quarterly change +5.5%

Valuation

P/E ratio 74.89
Enterprise value $532.4B
Beta 0.11

Balance sheet & scale

Income$6.3M
Revenue$64.4B
Cash$6.6B
Debt$70.8M
Income / Debt 0.09×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $470.5B

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,184.78 +0.11%
JNJ Johnson & Johnson $271.95 +0.27%
MRK Merck & Co., Inc. $148.69 -0.06%
RHHVF Roche Holding Ltd $444.62 -0.32%
NVS Novartis AG Sponsored ADR $146.88 +0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.